Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 10,832 | 5,119 | 259 | N/A |
| Receivables | 394 | 1,088 | 994 | N/A |
| Inventories | 187 | 179 | 357 | N/A |
| TOTAL | $11,734 | $6,785 | $2,055 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 1,153 | 1,214 | 928 | N/A |
| Other Non-Current Assets | 15 | 90 | 690 | 0 |
| TOTAL | $1,168 | $1,304 | $1,618 | $N/A |
| Total Assets | $12,902 | $8,089 | $3,673 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | N/A | 248 | 319 | N/A |
| Accounts payable and accrued liabilities | 242 | 1,300 | 100 | 0 |
| Accrued Expenses | 1,018 | 361 | 271 | N/A |
| Other current liabilities | 103 | 80 | N/A | N/A |
| TOTAL | $2,468 | $1,989 | $27,301 | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | N/A | N/A | 259 | N/A |
| Other Non-Current Liabilities | 24 | 109 | 0 | 0 |
| TOTAL | $24 | $109 | $259 | $N/A |
| Total Liabilities | $2,492 | $2,098 | $27,560 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 48 | 33 | N/A | N/A |
| Common Shares | 7 | 38 | N/A | N/A |
| Retained earnings | -17,968 | -6,640 | N/A | N/A |
| Other shareholders' equity | 0 | 0 | -23,887 | 0 |
| TOTAL | $10,410 | $5,991 | $-23,887 | $N/A |
| Total Liabilities And Equity | $12,902 | $8,089 | $3,673 | $0 |